Inhibition of macrophage chemotaxis by neoplastic and other rapidly proliferating cells in vitro
- PMID: 189909
Inhibition of macrophage chemotaxis by neoplastic and other rapidly proliferating cells in vitro
Abstract
Culture supernatants from rapidly proliferating cell lines inhibit macrophage chemotaxis. Of the cell lines tested, the supernatant from polyoma virus-induced tumor cells was the strongest inhibitor, although supernatants from simian virus 40-transformed 3T3, dimethylbenzanthracene-induced tumor cells, and Chinease hamster ovary fibroblasts also possessed inhibitory activity. The inhibitory substance(s) bound onto the macrophage cell surface. Although none of the culture supernatants examined were chemotactic for rat macrophages, they did possess weak attractive activity for polymorphonuclear neutrophils. This capacity of rapidly growing cells in culture to generate substances inhibitory to macrophage chemotaxis while attracting polymorphonuclear neutrophils may be relevant to the mechanism by which tumor bearing in vivo produces a cell-specific defect in chronic but not acute inflammation.
Similar articles
-
Detection of a polyoma virus-induced tumor-associated membrane antigen in mouse cells by the macrophage migration inhibition test.Cancer Res. 1986 Oct;46(10):5045-8. Cancer Res. 1986. PMID: 3019520
-
Characterization of macrophage chemotaxins in tumor cell cultures and comparison with lymphocyte-derived chemotactic factors.Cancer Res. 1977 Mar;37(3):721-5. Cancer Res. 1977. PMID: 837372
-
Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice.J Immunol. 1987 Apr 1;138(7):2372-9. J Immunol. 1987. PMID: 3104464
-
[Chemotactic activity of the leukocytes in the neoplastic process].Pol Tyg Lek. 1981 Oct 5;36(40):1561-4. Pol Tyg Lek. 1981. PMID: 7038643 Review. Polish. No abstract available.
-
The origin and function of tumor-associated macrophages.Immunol Today. 1992 Jul;13(7):265-70. doi: 10.1016/0167-5699(92)90008-U. Immunol Today. 1992. PMID: 1388654 Review.
Cited by
-
Resistance of neoplasms to immunological destruction: role of a macrophage chemotaxis inhibitor.J Exp Med. 1978 Jul 1;148(1):93-102. doi: 10.1084/jem.148.1.93. J Exp Med. 1978. PMID: 353219 Free PMC article.
-
Monocyte production in Hodgkin's disease and non-Hodgkin's lymphoma.Blut. 1978 Oct 13;37(4):193-200. doi: 10.1007/BF00996720. Blut. 1978. PMID: 359066
-
Antitumour responses induced by short-term pretreatment with tumour cells.Br J Cancer. 1978 Feb;37(2):269-81. doi: 10.1038/bjc.1978.36. Br J Cancer. 1978. PMID: 629863 Free PMC article.
-
Disordered function of mononuclear phagocytes in malignant disease.J Clin Pathol. 1983 Mar;36(3):316-23. doi: 10.1136/jcp.36.3.316. J Clin Pathol. 1983. PMID: 6338057 Free PMC article. Review. No abstract available.
-
Alveolar macrophage dysfunction in malignant lung tumours.Thorax. 1984 Jun;39(6):448-52. doi: 10.1136/thx.39.6.448. Thorax. 1984. PMID: 6463914 Free PMC article.